Irhythm Technologies Stock Performance
| IRTC Stock | USD 134.18 0.17 0.13% |
On a scale of 0 to 100, IRhythm Technologies holds a performance score of 10. The company retains a Market Volatility (i.e., Beta) of 1.21, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IRhythm Technologies will likely underperform. Please check IRhythm Technologies' semi variance, day typical price, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether IRhythm Technologies' current trending patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in iRhythm Technologies are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, IRhythm Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.43 | Five Day Return (2.24) | Year To Date Return 50.02 | Ten Year Return 415.09 | All Time Return 415.09 |
1 | iRhythm Technologies Beats Estimates, Forecasts Robust Growth | 05/05/2025 |
2 | iRhythm Technologies to Participate in Upcoming Investor Conferences | 05/21/2025 |
3 | Acquisition by Rubash Mark J of 1358 shares of IRhythm Technologies subject to Rule 16b-3 | 05/28/2025 |
4 | Acquisition by Snyderman Ralph of 1358 shares of IRhythm Technologies subject to Rule 16b-3 | 05/29/2025 |
5 | Acquisition by Turakhia Minang of 318 shares of IRhythm Technologies at 74.72 subject to Rule 16b-3 | 05/30/2025 |
6 | Disposition of 696 shares by Marc Rosenbaum of IRhythm Technologies at 140.21 subject to Rule 16b-3 | 06/02/2025 |
7 | Avanza Fonder AB Purchases Shares of 1,137 iRhythm Technologies, Inc. | 06/13/2025 |
8 | New Data Presented at ADA 2025 Highlights Burden and Risk Associations of Cardiac Arrhythmias in Patients with Type 2 Diabetes and Chronic Kidney Disease | 06/23/2025 |
9 | 1 Growth Stock with Impressive Fundamentals and 2 to Be Wary Of | 06/26/2025 |
10 | Patient Monitoring Stocks Q1 In Review iRhythm Vs Peers | 06/30/2025 |
11 | Insider Trading | 07/01/2025 |
12 | Disposition of 1420 shares by Turakhia Minang of IRhythm Technologies at 145.41 subject to Rule 16b-3 | 07/02/2025 |
13 | Morgan Stanley Raises iRhythm Price Target, Maintains Overweight Rating | 07/03/2025 |
14 | iRhythm Technologies Inc Announces Board Changes with New Appointments IRTC stock news | 07/07/2025 |
15 | iRhythm Stock Trades Up, Here Is Why | 07/14/2025 |
16 | iRhythm Technologies Inc Announces Upcoming Q2 2025 Financial Results Release IRTC ... | 07/17/2025 |
17 | SHAREHOLDER ALERT Morris Kandinov Investigating AVDX, IRTC, HAYW, and ITOS Shareholders are Encouraged to Contact the Firm | 07/24/2025 |
| Begin Period Cash Flow | 36.2 M | |
| Total Cashflows From Investing Activities | -123 M |
IRhythm Technologies Relative Risk vs. Return Landscape
If you would invest 10,664 in iRhythm Technologies on April 27, 2025 and sell it today you would earn a total of 2,754 from holding iRhythm Technologies or generate 25.83% return on investment over 90 days. iRhythm Technologies is currently generating 0.408% in daily expected returns and assumes 3.0746% risk (volatility on return distribution) over the 90 days horizon. In different words, 27% of stocks are less volatile than IRhythm, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
IRhythm Technologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRhythm Technologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as iRhythm Technologies, and traders can use it to determine the average amount a IRhythm Technologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1327
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IRTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.07 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.41 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average IRhythm Technologies is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IRhythm Technologies by adding it to a well-diversified portfolio.
IRhythm Technologies Fundamentals Growth
IRhythm Stock prices reflect investors' perceptions of the future prospects and financial health of IRhythm Technologies, and IRhythm Technologies fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IRhythm Stock performance.
| Return On Equity | -1.11 | ||||
| Return On Asset | -0.0437 | ||||
| Profit Margin | (0.16) % | ||||
| Operating Margin | (0.19) % | ||||
| Current Valuation | 4.44 B | ||||
| Shares Outstanding | 31.93 M | ||||
| Price To Earning | (36.08) X | ||||
| Price To Book | 48.73 X | ||||
| Price To Sales | 6.83 X | ||||
| Revenue | 591.84 M | ||||
| Gross Profit | 429.23 M | ||||
| EBITDA | (74.13 M) | ||||
| Net Income | (113.29 M) | ||||
| Cash And Equivalents | 204.49 M | ||||
| Cash Per Share | 6.81 X | ||||
| Total Debt | 736.91 M | ||||
| Debt To Equity | 0.54 % | ||||
| Current Ratio | 4.05 X | ||||
| Book Value Per Share | 2.71 X | ||||
| Cash Flow From Operations | 3.39 M | ||||
| Earnings Per Share | (3.14) X | ||||
| Market Capitalization | 4.22 B | ||||
| Total Asset | 931.45 M | ||||
| Retained Earnings | (758.89 M) | ||||
| Working Capital | 534.9 M | ||||
| Current Asset | 54.91 M | ||||
| Current Liabilities | 11.97 M | ||||
About IRhythm Technologies Performance
By analyzing IRhythm Technologies' fundamental ratios, stakeholders can gain valuable insights into IRhythm Technologies' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IRhythm Technologies has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IRhythm Technologies has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 27.80 | 23.05 | |
| Return On Tangible Assets | (0.12) | (0.13) | |
| Return On Capital Employed | (0.14) | (0.15) | |
| Return On Assets | (0.12) | (0.13) | |
| Return On Equity | (1.25) | (1.18) |
Things to note about iRhythm Technologies performance evaluation
Checking the ongoing alerts about IRhythm Technologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for iRhythm Technologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| iRhythm Technologies had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 591.84 M. Net Loss for the year was (113.29 M) with profit before overhead, payroll, taxes, and interest of 429.23 M. | |
| iRhythm Technologies has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: SHAREHOLDER ALERT Morris Kandinov Investigating AVDX, IRTC, HAYW, and ITOS Shareholders are Encouraged to Contact the Firm |
- Analyzing IRhythm Technologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IRhythm Technologies' stock is overvalued or undervalued compared to its peers.
- Examining IRhythm Technologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IRhythm Technologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IRhythm Technologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IRhythm Technologies' stock. These opinions can provide insight into IRhythm Technologies' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for IRhythm Stock analysis
When running IRhythm Technologies' price analysis, check to measure IRhythm Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRhythm Technologies is operating at the current time. Most of IRhythm Technologies' value examination focuses on studying past and present price action to predict the probability of IRhythm Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRhythm Technologies' price. Additionally, you may evaluate how the addition of IRhythm Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |